Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2000 Feb;50(451):143–146.

Not so simple cystitis: how should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria?

P Davey 1, D Steinke 1, T MacDonald 1, G Phillips 1, F Sullivan 1
PMCID: PMC1313635  PMID: 10750215

Abstract

Trimethoprim is a safe, effective, and inexpensive treatment for cystitis. However, at least 25% of bacteria isolated from urine samples in general practice are now resistant to trimethoprim in the laboratory. The relationship between laboratory resistance and clinical outcome is complex. Cephalexin appears to be more active than trimethoprim in the laboratory but has been consistently less effective in clinical trials. There is little point in collecting data about the prevalence of drug resistance in urinary bacteria unless it is linked to evidence about the impact of resistance on clinical outcomes. Pragmatic clinical trials are required to provide practices with clear thresholds for managing their antibiotic policies; for example, 'Change from trimethoprim to drug X when the probability of trimethoprim resistance reaches Y%.' Prescribers should be aware that trimethoprim resistance is most likely to occur in patients who have been exposed to trimethoprim or other antibiotics in the previous six months, and that the risk increases with age. This information could be used to stratify women according to risk of infection by trimethoprim-resistant bacteria. Health education leaflets are an effective method for reducing the frequency of recurrent cystitis. Symptomatic treatment can control symptoms and allow time for microbiological investigation. Both of these strategies may help to reduce unnecessary prescribing of antibiotics in general and quinolones in particular.

Full Text

The Full Text of this article is available as a PDF (43.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adrian P. V., Koornhof H. J., Wylie B. A. Trimethoprim resistance in South African isolates of aerobic gram-negative faecal flora. Eur J Clin Microbiol Infect Dis. 1993 Dec;12(12):916–921. doi: 10.1007/BF01992165. [DOI] [PubMed] [Google Scholar]
  2. Banks J. C., Howie J. G. Reducing consultations for symptoms of cystitis using a health education leaflet. Br J Gen Pract. 1998 Sep;48(434):1595–1596. [PMC free article] [PubMed] [Google Scholar]
  3. Bannister P., Crosse B. Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit. J R Soc Med. 1989 Mar;82(3):145–146. doi: 10.1177/014107688908200310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brauner A., Dornbusch K., Hallander H. O. beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection. Scand J Infect Dis Suppl. 1978;(13):67–72. [PubMed] [Google Scholar]
  5. Brumfitt W., Pursell R. Double-blind trial to compare ampicillin, cephalexin, co-trimoxazole, and trimethoprim in treatment of urinary infection. Br Med J. 1972 Jun 17;2(5815):673–676. doi: 10.1136/bmj.2.5815.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carlson K. J., Mulley A. G. Management of acute dysuria. A decision-analysis model of alternative strategies. Ann Intern Med. 1985 Feb;102(2):244–249. doi: 10.7326/0003-4819-102-2-244. [DOI] [PubMed] [Google Scholar]
  7. Cheung R., Sullens C. M., Seal D., Dickins J., Nicholson P. W., Deshmukh A. A., Denham M. J., Dobbs S. M. The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community. Br J Clin Pharmacol. 1988 Oct;26(4):391–398. doi: 10.1111/j.1365-2125.1988.tb03396.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coast J., Smith R. D., Millar M. R. An economic perspective on policy to reduce antimicrobial resistance. Soc Sci Med. 1998 Jan;46(1):29–38. doi: 10.1016/s0277-9536(97)00132-9. [DOI] [PubMed] [Google Scholar]
  9. Cohen M. L. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992 Aug 21;257(5073):1050–1055. doi: 10.1126/science.257.5073.1050. [DOI] [PubMed] [Google Scholar]
  10. Davey P. G., Malek M. M., Parker S. E. Pharmacoeconomics of antibacterial treatment. Pharmacoeconomics. 1992 Jun;1(6):409–437. doi: 10.2165/00019053-199201060-00003. [DOI] [PubMed] [Google Scholar]
  11. Ena J., Amador C., Martinez C., Ortiz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol. 1995 Jan;153(1):117–120. doi: 10.1097/00005392-199501000-00040. [DOI] [PubMed] [Google Scholar]
  12. Finkelstein R., Kassis E., Reinhertz G., Gorenstein S., Herman P. Community-acquired urinary tract infection in adults: a hospital viewpoint. J Hosp Infect. 1998 Mar;38(3):193–202. doi: 10.1016/s0195-6701(98)90274-2. [DOI] [PubMed] [Google Scholar]
  13. Gallacher G., Erwin L., Scott P. J., Sleigh J. D. Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly. J Infect. 1986 May;12(3):229–233. doi: 10.1016/s0163-4453(86)94164-2. [DOI] [PubMed] [Google Scholar]
  14. Goldstein E. J., Alpert M. L., Ginsberg B. P. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections. Antimicrob Agents Chemother. 1985 Mar;27(3):422–423. doi: 10.1128/aac.27.3.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gower P. E., Tasker P. R. Comparative double-blind study of cephalexin and co-trimoxazole in urinary tract infections. Br Med J. 1976 Mar 20;1(6011):684–686. doi: 10.1136/bmj.1.6011.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gupta K., Scholes D., Stamm W. E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999 Feb 24;281(8):736–738. doi: 10.1001/jama.281.8.736. [DOI] [PubMed] [Google Scholar]
  17. Hassay K. A. Effective management of urinary discomfort. Nurse Pract. 1995 Feb;20(2):36, 39-40, 42-4, passim. [PubMed] [Google Scholar]
  18. Hooton T. M., Johnson C., Winter C., Kuwamura L., Rogers M. E., Roberts P. L., Stamm W. E. Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. Antimicrob Agents Chemother. 1991 Jul;35(7):1479–1483. doi: 10.1128/aac.35.7.1479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hooton T. M., Latham R. H., Wong E. S., Johnson C., Roberts P. L., Stamm W. E. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother. 1989 Aug;33(8):1308–1312. doi: 10.1128/aac.33.8.1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hooton T. M., Winter C., Tiu F., Stamm W. E. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA. 1995 Jan 4;273(1):41–45. [PubMed] [Google Scholar]
  21. Iqbal J., Rahman M., Kabir M. S., Rahman M. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in Bangladesh. Jpn J Med Sci Biol. 1997 Dec;50(6):241–250. doi: 10.7883/yoken1952.50.241. [DOI] [PubMed] [Google Scholar]
  22. Kapoor H., Aggarwal P. Resistance to quinolones in pathogens causing urinary tract infections. J Commun Dis. 1997 Sep;29(3):263–267. [PubMed] [Google Scholar]
  23. Lamikanra A., Ndep R. B. Trimethoprim resistance in urinary tract pathogens in two Nigerian hospitals. J Antimicrob Chemother. 1989 Jan;23(1):151–154. doi: 10.1093/jac/23.1.151. [DOI] [PubMed] [Google Scholar]
  24. MacDonald T. M., Collins D., McGilchrist M. M., Stevens J., McKendrick A. D., McDevitt D. G., Davey P. G. The utilisation and economic evaluation of antibiotics prescribed in primary care. J Antimicrob Chemother. 1995 Jan;35(1):191–204. doi: 10.1093/jac/35.1.191. [DOI] [PubMed] [Google Scholar]
  25. McGavock H., Webb C. H., Johnston G. D., Milligan E. Market penetration of new drugs in one United Kingdom region: implications for general practitioners and administrators. BMJ. 1993 Oct 30;307(6912):1118–1120. doi: 10.1136/bmj.307.6912.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Neu H. C. The crisis in antibiotic resistance. Science. 1992 Aug 21;257(5073):1064–1073. doi: 10.1126/science.257.5073.1064. [DOI] [PubMed] [Google Scholar]
  27. O'Brien T. F. Global surveillance of antibiotic resistance. N Engl J Med. 1992 Jan 30;326(5):339–340. doi: 10.1056/NEJM199201303260510. [DOI] [PubMed] [Google Scholar]
  28. Ode B., Walder M., Forsgren A. Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. Scand J Infect Dis. 1987;19(6):677–679. doi: 10.3109/00365548709117203. [DOI] [PubMed] [Google Scholar]
  29. Olesen B., Kolmos H. J., Orskov F., Orskov I. A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University Hospital. J Hosp Infect. 1995 Dec;31(4):295–304. doi: 10.1016/0195-6701(95)90208-2. [DOI] [PubMed] [Google Scholar]
  30. Patton J. P., Nash D. B., Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am. 1991 Mar;75(2):495–513. doi: 10.1016/s0025-7125(16)30466-7. [DOI] [PubMed] [Google Scholar]
  31. Stamm W. E., McKevitt M., Roberts P. L., White N. J. Natural history of recurrent urinary tract infections in women. Rev Infect Dis. 1991 Jan-Feb;13(1):77–84. doi: 10.1093/clinids/13.1.77. [DOI] [PubMed] [Google Scholar]
  32. Thomson K. S., Sanders C. C. The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones. J Antimicrob Chemother. 1998 Aug;42(2):179–187. doi: 10.1093/jac/42.2.179. [DOI] [PubMed] [Google Scholar]
  33. Urbina R., Prado V., Canelo E. Trimethoprim resistance in enterobacteria isolated in Chile. J Antimicrob Chemother. 1989 Jan;23(1):143–149. doi: 10.1093/jac/23.1.143. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES